Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Recurrent Pseudomonas aeruginosa Infection in Chronic Lung Diseases: Relapse or Reinfection?

  • Yum, Ho-Kee (Department of Internal Medicine, Inje University Seoul Paik Hospital) ;
  • Park, I-Nae (Department of Internal Medicine, Inje University Seoul Paik Hospital) ;
  • Shin, Bo-Mun (Department of Laboratory Medicine, Inje University Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Choi, Soo-Jeon (Department of Laboratory Medicine, Inje University Sanggye Paik Hospital, Inje University College of Medicine)
  • Received : 2014.03.05
  • Accepted : 2014.08.18
  • Published : 2014.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Pseudomonas aeruginosa infection is particularly associated with progressive and ultimately chronic recurrent respiratory infections in chronic obstructive pulmonary disease, bronchiectasis, chronic destroyed lung disease, and cystic fibrosis. Its treatment is also very complex because of drug resistance and recurrence. Methods: Forty eight cultures from 18 patients with recurrent P. aeruginosa pneumonia from 1998 to 2002 were included in this study. Two or more pairs of sputum cultures were performed during 2 or more different periods of recurrences. The comparison of strains was made according to the phenotypic patterns of antibiotic resistance and chromosomal fingerprinting by pulsed field gel electrophoresis (PFGE) using the genomic DNA of P. aeruginosa from the sputum culture. Results: Phenotypic patterns of antibiotic resistance of P. aeruginosa were not correlated with their prior antibiotic exposition. Fifteen of 18 patients (83.3%) had recurrent P. aeruginosa pneumonia caused by the strains with same PFGE pattern. Conclusion: These data suggest that the most of the recurrent P. aeruginosa infections in chronic lung disease occurred due to the relapse of prior infections. Further investigations should be performed for assessing the molecular mechanisms of the persistent colonization and for determining how to eradicate clonal persistence of P. aeruginosa.

Keywords

References

  1. Dowling RB, Wilson R. Pseudomonas aeruginosa respiratory infections. Clin Pulm Med 1999;6:278-86. https://doi.org/10.1097/00045413-199909000-00002
  2. Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989;87:540-6. https://doi.org/10.1016/S0002-9343(89)80611-4
  3. Moss RB, Wunderink RG. Strategies for drug therapy in treating Pseudomonas infection. J Respir Dis 1996;17:806-9.
  4. Fink MP, Snydman DR, Niederman MS, Leeper KV Jr, Johnson RH, Heard SO, et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrob Agents Chemother 1994;38:547-57. https://doi.org/10.1128/AAC.38.3.547
  5. Rello J, Mariscal D, March F, Jubert P, Sanchez F, Valles J, et al. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am J Respir Crit Care Med 1998;157(3 Pt 1):912-6. https://doi.org/10.1164/ajrccm.157.3.9703014
  6. Talon D, Capellier G, Boillot A, Michel-Briand Y. Use of pulsed-field gel electrophoresis as an epidemiologic tool during an outbreak of Pseudomonas aeruginosa lung infections in an intensive care unit. Intensive Care Med 1995;21:996-1002. https://doi.org/10.1007/BF01700661
  7. Silver DR, Cohen IL, Weinberg PF. Recurrent Pseudomonas aeruginosa pneumonia in an intensive care unit. Chest 1992;101:194-8. https://doi.org/10.1378/chest.101.1.194
  8. Crouch Brewer S, Wunderink RG, Jones CB, Leeper KV Jr. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1996;109:1019-29. https://doi.org/10.1378/chest.109.4.1019
  9. Boukadida J, De Montalembert M, Lenoir G, Scheinmann P, Veron M, Berche P. Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis. J Med Microbiol 1993;38:29-33. https://doi.org/10.1099/00222615-38-1-29
  10. Doring G, Horz M, Ortelt J, Grupp H, Wolz C. Molecular epidemiology of Pseudomonas aeruginosa in an intensive care unit. Epidemiol Infect 1993;110:427-36. https://doi.org/10.1017/S0950268800050858
  11. Poh CL, Yeo CC, Tay L. Genome fingerprinting by pulsed-field gel electrophoresis and ribotyping to differentiate Pseudomonas aeruginosa serotype O11 strains. Eur J Clin Microbiol Infect Dis 1992;11:817-22. https://doi.org/10.1007/BF01960881
  12. Kirschke DL, Jones TF, Craig AS, Chu PS, Mayernick GG, Patel JA, et al. Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes. N Engl J Med 2003;348:214-20. https://doi.org/10.1056/NEJMoa021791
  13. Spencker FB, Haupt S, Claros MC, Walter S, Lietz T, Schille R, et al. Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis. Clin Microbiol Infect 2000;6:600-7. https://doi.org/10.1046/j.1469-0691.2000.00171.x
  14. Poh CL, Yeo CC. Recent advances in typing of Pseudomonas aeruginosa. J Hosp Infect 1993;24:175-81. https://doi.org/10.1016/0195-6701(93)90047-4
  15. Renders N, Romling Y, Verbrugh H, van Belkum A. Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments. J Clin Microbiol 1996;34:3190-5.
  16. Niederman MS, Ferranti RD, Zeigler A, Merrill WW, Reynolds HY. Respiratory infection complicating long-term tracheostomy. The implication of persistent gram-negative tracheobronchial colonization. Chest 1984;85:39-44. https://doi.org/10.1378/chest.85.1.39

Cited by

  1. Pseudomonas aeruginosa in Dairy Goats: Genotypic and Phenotypic Comparison of Intramammary and Environmental Isolates vol.10, pp.11, 2014, https://doi.org/10.1371/journal.pone.0142973
  2. Increased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis vol.18, pp.8, 2014, https://doi.org/10.3390/ijms18081752
  3. Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study vol.18, pp.None, 2014, https://doi.org/10.1186/s12879-018-3612-9
  4. Mesoscopic Energy Minimization Drives Pseudomonas aeruginosa Biofilm Morphologies and Consequent Stratification of Antibiotic Activity Based on Cell Metabolism vol.62, pp.5, 2014, https://doi.org/10.1128/aac.02544-17
  5. Risk Factors for Same Pathogen Sepsis Readmission Following Hospitalization for Septic Shock vol.8, pp.2, 2014, https://doi.org/10.3390/jcm8020181
  6. Quorum quenching intervened in vivo attenuation and immunological clearance enhancement by Solanum torvum root extract against Pseudomonas aeruginosa instigated pneumonia in Sprague Dawley rats vol.5, pp.None, 2014, https://doi.org/10.1186/s40816-019-0120-4
  7. Effect of colistin-based antibiotic combinations on the eradication of persister cells in Pseudomonas aeruginosa vol.75, pp.4, 2014, https://doi.org/10.1093/jac/dkz552
  8. Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trial vol.24, pp.None, 2020, https://doi.org/10.1186/s13054-020-2792-z
  9. Bacterial Manipulation of the Integrated Stress Response: A New Perspective on Infection vol.12, pp.None, 2021, https://doi.org/10.3389/fmicb.2021.645161
  10. Contribution of Drugs Interfering with Protein and Cell Wall Synthesis to the Persistence of Pseudomonas aeruginosa Biofilms: An In Vitro Model vol.22, pp.4, 2021, https://doi.org/10.3390/ijms22041628
  11. Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation vol.13, pp.6, 2021, https://doi.org/10.4155/fmc-2020-0297
  12. Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis vol.9, pp.3, 2014, https://doi.org/10.1128/spectrum.00802-21